Pharmacokinetic profile of Ivermectin in cattle dung excretion, and its associated environmental hazard

Soil and Sediment Contamination

Volumn 18, Issue 5, 2009, Pages 564-575

  Fernandez, Carlos ^a   Andŕes, Manuel San ^b   Porce, Miguel Angel ^a   Rodriguez, Casilda ^b   Alonso, Alvaro ^a   Tarazona, José Vicente ^a  

^a INIA   (Spain)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Dung; ERA; Ivermectin; Pharmacokinetic; Plasma

Indexed keywords

ACUTE TOXICITY; AGRICULTURAL LAND; AQUATIC ECOSYSTEM; CATTLE DUNG; DIRECT EMISSIONS; DUNG; ENVIRONMENTAL HAZARDS; ENVIRONMENTAL RISK ASSESSMENT; ERA; IVERMECTIN; MANURE APPLICATIONS; PHARMACOKINETIC PROFILES; POTENTIAL EFFECTS; POTENTIAL HAZARDS; SOIL ORGANISMS;

ANIMALS; MANURES; PHARMACOKINETICS; RISK ASSESSMENT; RISK MANAGEMENT; TOXICITY;

AGRICULTURE;

BOS; INVERTEBRATA;

EID: 70449451007     PISSN: 15320383     EISSN: 15497887     Source Type: Journal    
DOI: 10.1080/15320380903085675     Document Type: Article

References (48)

1. Barber, S., Bowles, V., Lespine, A., and Alvinerie, M. 2003. The comparative serum disposition kinetics of subcutaneous administration of doramectin, ivermectin and moxidectin in the Australian Merino sheep. J. Vet. Pharmacol. Ther. 26, 343-348.
2. Bogan, J.A., and McKellar, Q.A. 1988. The pharmacodynamics of ivermectin in sheep and cattle. J. Vet. Pharmacol. Ther. 11, 260-268.
3. Boxall, A.B., Fogg, L.A., Blackwell, P.A., Kay, P., Pemberton, E.J., and Croxford, A. 2004. Veterinary medicines in the environment. Reviews of Environmental Contamination and Toxicology 180, 1-91.
4. Burg, R.W., Miller, B.M., Baker, E.E., Birnbaum, J., Currie, S.A., Hartmen, R., Kong, Y.L., Monaghan, R.L., Olson, G., Putter, I., Tanac, J.B., Wallick, H., Stapley, E.O., Oiwa, R., and Omura, S. 1979. Avermectins, a new family of potent antihelmintic agents: producing organism and fermentation. Antimicrobial Agents and Chemotherapy 15, 361-367.
5. Campbell,W.C.,Fisher,M.H.,Stapley,E.O.,Albers-Schonberg,G.,andJacob,T.A.1983.Ivermectin: a potent new antiparasitic agent. Science 221, 823-828.
6. Canga, A.G., Sahagun, A., Diez, M.J., Fernandez, N., Sierra, M., and Garcia, J.J. 2007. Bioavailability of a commercial formulation of ivermectin after subcutaneous administration to sheep. Am. J. Vet. Res. 68(1), 101-106.
7. Cerkvenik, V., Perko, B., Rogelj, I., Doganoc, D.Z., Skubic, V., Beek, W.M.J., and Keukens, H.J. 2004. Fate of ivermectin residues in ewes' milk and derived products. J. Dairy Res. 71, 39-45.
8. Chapman, A., Gray, J., Taylor, K., and Barrett, K.L. 2003. Development of a toxicity test method using the dung beetle Onthophagus taurus. Abstracts, ENVIRPHARMA Conference, Lyon, France, April 2003, 14-16, 60.
9. Chiu, S., Green, M.L., Bayliss, F.P., Eline, D., Rosegay, A., Meriwether, H., and Jacob, T.A. 1990. Absorption, tissue distribution, and excretion of tritium-labeled ivermectin in cattle, sheep, and rat. Journal of Agricultural and Food Chemistry 38, 2072-2078.
10. Cook, D.F., Dadour, I.R., and Ali, D.N. 1996. Effect of diet on the excretion profile of ivermectin in cattle dung. International Journal for Parasitology 26, 291-295.
11. De Montigny, P., Shim, J.S.K., and Pivnichny, J.V. 1990. Liquid-chromatographic determination of ivermectin in animal plasma with trifluoroacetic-anhydride and N-methylimidazole as the derivatization agent. J. Pharm. and Biomed. Chrom. 18, 117-124.
12. Dybas, R.A. 1989. Abamectin in corp protection. In Campbell, W.C. (ed.), Ivermectin and Abamectin, Springer-Verlag, New York.
13. Edwards, C.A., Atiyeh, R.M., and Römbke, J. 2001. Environmental impact of avermectins. Reviews Environmental Contamination Toxicology. 171, 111-137.
14. Edwards, G., and Krishna, S. 2004. Pharmacokinetic and pharmacodynamic issues in the treatment of parasitic infections. Eur. J. Clin. Microbiol. Infect. Dis. 23, 233-242.
15. EMEA. 2008. Environmental Impact Assessment for Veterinary Medicinal Products in Support of the VICH Guidelines GL6 and GL38. Doc.Ref.EMEA/CVMP/VICH/790/03/FINAL. London, January 2005.
16. Errouissi, F., Alvinerie, M., Galtier, P., Kerboeuf, D., and Lumaret, J.P. 2001. The negative effects of the residues of ivermectin in cattle dung using a sustained-release bolus on Aphodius constans (Duft.) Coleoptera: Aphodiidae. Vet. Res. 32, 421-427.
17. FDA (Food and Drug Administration). 1986. Animal drugs, feeds, and related products; ivermectin injection. Department of Health and Human Services. US Federal Register 51(145), 27020-27021.
18. Fink, D.W., and Porras, A.G. 1989. Pharmacokinetics of ivermectin in animals and humans. In: Ivermectin and Abamectin, Campbell, W.C. (ed.), Springer-Verlag, New York, pp. 113-130.
19. Fisher, M.H., and Mrozik, H. 1992. The chemistry and pharmacology of avermectins. Ann. Rev. Pharmacol. Toxicol. 32, 537-553.
20. Floate, K.D., and Fox, A.S. 1999. Indirect effects of ivermectin residues across trophic levels: Musca domestica (Diptera: Muscidae) and Muscidifurax zaraptor (Hymenoptera: Pteromalidae). Bulletin of Entomological Research 89, 225-229.
21. Floate, K.D., Wardhaugh, K.G., Boxall, A.B., and Sherratt, T.N. 2005. Fecal residues of veterinary parasiticides: nontarget effects in the pasture environment. Annual Reviews Entomology. 50, 153-179.
22. Garric, J., Vollat, B., Duis, K., Péry, A., Junker, T., Ramil, M., Fink, G., and Ternes, TA. 2007. Effects of the parasiticide ivermectin on the cladoceran Daphnia magna and the green alga Pseudokirchneriella subcapitata. Chemosphere 69, 903-910.
23. Gover, J., and Strong, L. 1996. Determination of the toxicity of faeces of cattle treated with an ivermectin sustained-release bolus and preference trials using a dung fly, Neomyia cornicia. Entomologia Experimentalis et Applicata 81, 133-139.
24. Gunn, A., and Sadd, J.W. 1994. The effect of ivermectin on the survival, behaviour and cocoon production of the earthworm Eisenia fetida. Pedobiologia 38, 327-333.
25. Halley, B.A., Jacob, T.A., and Lu, A.Y.H. 1989. The environmental effects of the use of ivermectin: environmental effects and fate. Chemosphere 18, 1543-1563.
26. Iglesias, L.E., Saumell, C.A., Fernández, A.S., Fusé, L.A., Lifschitz, A.L., Rodríguez, E.M., Steffan, P.E., and Fiel, C.A. 2006. Environmental impact of ivermectin excreted by cattle treated in autumn on dung fauna and degradation of faeces on pasture. Parasitology Research 100, 93-102.
27. Jensen, J., Krogh, P.H., and Sverdrup, L.E. 2003. Effects of the antibacterial agents tiamulin, olan-quindox and metronidazole and the anthelmintic ivermectin on the soil invertebrate species Folsomia fimetaria (Collembola) and Enchytraeus crypticus (Enchytraeidae). Chemosphere 50, 437-443.
28. Kilmartin, J., Cazabon, D., and Smith, P. 1996. Investigations of the toxicity of ivermectin for salmonids. Bulletin of the European Association of Fish Pathologists 17, 58-61.
29. Kolar, L., and Kozuh Erzen, N. 2006. Veterinary parasiticides-are they posing an environmental risk? Slovenian Veterinary Research 43, 85-96.
30. Kolar, L., Kuzner, J., and Erzen, N.K. 2004. Determination of abamectin and doramectin in sheep faeces using HPLC with fluorescence detection. Biomedical Chromatography. 8, 507-511.
31. Kools, S.A., Boxall, A., Moltmann, J.F., Bryning, G., Koschorreck, J., and Knacker, T. 2008. A ranking of European veterinary medicines based on environmental risks. Integr. Environ. Assess Manag. 4(4), 399-408.
32. Lanusse,C.E.,and Prichard,R.K 1993. Relationship between pharmacological properties and clinical efficacy of ruminant anthelminyics. Vet. Parasitol. 49, 123-158.
33. Lanusse, C.E., Lifschitz, A., Virkel, G., Alvarez, L., Sanchez, S., Sutra, J.F., Galtier, P., and Alvinerie M. 1997. Comparative plasma disposition kinetics of ivermectin, moxidectin and doramectin in cattle. J. Vet. Pharmacol. Ther. 20, 91-99.
34. Lifschitz, A., Virkel, G., Pis, A., Imperiale, F., Sanchez, S., Alvarez, L., Kujanek, R., and Lanusse C. 1999. Ivermectin disposition kinetics after subcutaneous and intramuscular administration of an oil-based formulation to cattle. Vet. Parasitol. 86, 203-215.
35. Lo, P.A., Fink, D.W., Williams, J.B., and Blodinger, J. 1985. Phamacokinetic studies of ivermectin: effects of formulation. Vet. Res. Commun. 9, 251-268.
36. McKellar, Q.A., and Benchaoui, H.A. 1996. Avermectins and milbemycins. J. Vet. Pharmacol. Therap. 19, 331-351.
37. Prieto, J.G., Merino, G., Pulido, M.M., Estevez, E., Molina, A.J., Vila, L., and Alvarez, A.I. 2003. Improved LC method to determine ivermectin in plasma. J. Pharm. Biomed. Anal. 31, 639-645.
38. Shoop, W., Mrozik, H., and Fisher, M. 1995. Structure and activity of avermectins and milbemycins in animal health. Vet. Parasitol. 59, 139-156.
39. Sommer, C., Steffansen, B., Overgaard Nielsen, B., Gronvold, J., Vagn Jensen, K.M., Brochner Jespersen, J., Springborg, J., and Nansen, P. 1992. Ivermectin excreted in cattle dung after subcutaneous injection or pouron treatment: concentrations and impact on dung fauna. Bull. Entomol. Res. 82, 257-264.
40. Sommer, C., and Steffansen, B. 1993. Changes with time after treatment in the concentrations of ivermectin in fresh cow dung and in cow pats aged in the field. Vet. Parasitol. 48, 67-73.
41. Sun, Y., Diao, X., Zhang, Q., and Shen, J. 2005. Bioaccumulation and elimination of avermectin B1a in the earthworms (Eisenia fetida). Chemosphere 60, 699-704.
42. Toutain, P.L., Upson, D.W., Terhune, T.N., and Mckenzie, M.E. 1997. Comparative pharmacokinetics of doramectin and ivermectin in cattle. Vet. Parasitol. 72, 3-8.
43. Toutain, P.L. 2002. Pharmacokinetic/pharmacodynamic integration in drug development and dosage-regimen optimization for veterinary medicine. Pharm. Sci. 4, 38. DOI: 10.1208/ps040438.
44. Vercruysse, J., Deprez, P., Everaert, D., Bassissi, F., and Alvinerie, M. 2008. Breed differences in the pharmacokinetics of ivermectin administered subcutaneously to Holstein and Belgian Blue calves. Vet. Parasitol. 152, 136-40.
45. VICH. EMEA. Guideline on impact assessment (EIAs) for veterinary medicinal products (VMPs)-Phase I. Doc.Ref.EMEA/CVMP/ERA/418282/2005-Rev. 1. London, November 2008.
46. VICH. EMEA. Guideline on impact assessment (EIAs) for veterinary medicinal products (VMPs)-Phase II. Doc.Ref.EMEA/CVMP/VICH/592/98/03/FINAL. London, July 2000.
47. Wilkinson, P.K., Pope, D.G., and Baylis, F.P. 1985. Pharmacokinetics of ivermectin administered intravenously to cattle. J. Pharm. Sci. 74, 1105-1107.
48. Xu, F.R., Pan, B.L., Wang, Y.W., Pan, Z.D., Dai, X.X., Liu, P.H., and Wang, M. 2007. Pharma-cokinetics of injectable long-acting ivermectin aqueous suspension following subcutaneous administration in sheep. J. Vet. Pharmacol. Ther. 30, 486-488.